Luís Cláudio Lemos Correia

Escola Bahiana de Medicina e Saúde Pública

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Márcia Noya-Rabelo

Escola Bahiana de Medicina e Saúde Pública

J. Péricles Esteves

Hospital de Egas Moniz

Guilherme J. M. Garcia

Universidade de Pernambuco

Manuela Carvalhal

Escola Bahiana de Medicina e Saúde Pública

Luis Correia

Emory University

Jéssica Gonzalez Suerdieck

AC Camargo Hospital

Fernanda Oliveira de Andrade Lopes

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Thiago Menezes Barbosa de Souza

Escola Bahiana de Medicina e Saúde Pública

Ana Marice Teixeira Ladeia

Universidade de São Paulo

Christoph Liebetrau

University of Giessen

Cooperative Institutions

Escola Bahiana de Medicina e Saúde Pública

203

Universidade de São Paulo

107

Universidade Federal da Bahia

105

Hospital São Rafael

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Fundação Oswaldo Cruz

Sociedade Brasileira de Cardiologia

Hospital Ana Nery

Complexo Hospitalar Universitário Professor Edgard Santos

Universidade Federal de São Paulo

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

The yearly cost of formatting and why Evidence decided to focus on science and not on a favourite typeface

Journal of Evidence-Based Healthcare (2020)

João de Deus Barreto Segundo Luís Cláudio Lemos Correia

Favourite

Typeface

Disk formatting

10.17267/2675-021xevidence.v1i2.2725

Cite

Citations (0)

DOES GRACE SCORE INCREMENT PROGNOSTIC ASSESSMENT AFTER ANGIOGRAPHY IN ACUTE CORONARY SYNDROMES?

Brazilian Journal of Medicine and Human Health (2013)

Guilherme J. M. Garcia Rafael Freitas Felipe Kalil Felipe Ferreira André Silva

Rational: The GRACE Score assessed at admission predicts mortality in patients with non-ST elevation acute coronary syndromes (ACS). However, once coronary anatomy is assessed, it is not known whether this score increments prognostic assessment. Objective: To test the hypothesis that the GRACE Score adds prognostic value to coronary anatomy in patients with ACS. Methods: Prospective cohort, including patients with ACS who underwent coronary angiography while admitted to the hospital. Anatomical extension of coronary disease was characterized by the Duke Jeopardy score (DJS) and the number diseased artery (NDA). The primary end-point was the composite of death, non-fatal MI or refractory unstable angina. Results: 112 patients enrolled, aged 70 ± 12, 14% incidence of cardiovascular events. C-statistics for GRACE was 0.68 (95%CI=0.53-0.84), for DJS was 0.78 (95%CI=0.67-0.9) and for NAD was 0.74 (95%CI=0.61-0.88). Logistic regression analysis demonstrated independent predictive value of GRACE in relation to anatomical information. However, when this Score was added to DJS or NDA, no improving in c-statistic was observed: DJS-GRACE had a c-statistics of 0.78 (95%CI=0.64–0.92) and NAD-GRACE of 0.76 (95%CI=0.60–0.92). Conclusion: The GRACE score does not add prognostic value to angiographic data in patients with ACS.

Unstable angina

10.17267/2317-3386bjmhh.v1i2.228

Cite

Citations (0)

An immunization program against the COVID-19 infodemic

Journal of Evidence-Based Healthcare (2020)

Luís Cláudio Lemos Correia João de Deus Barreto Segundo

An immunization program against the COVID-19 infodemic

2019-20 coronavirus outbreak

Pandemic

10.17267/2675-021xevidence.v2i1.3124

Cite

Citations (6)

Incremental Prognostic Value of Conventional Echocardiography in Patients with Acutely Decompensated Heart Failure

Figshare (2017)

Fabio Soares Janine Magalhães Garcia de Oliveira Gabriel Neimann Da Cunha Freire Lucas Carvalho Andrade Márcia Noya-Rabelo

Abstract Background: Acutely decompensated heart failure (ADHF) presents high morbidity and mortality in spite of therapeutic advance. Identifying factors of worst prognosis is important to improve assistance during the hospital phase and follow-up after discharge. The use of echocardiography for diagnosis and therapeutic guidance has been of great utility in clinical practice. However, it is not clear if it could also be useful for risk determination and classification in patients with ADHF and if it is capable of adding prognostic value to a clinical score (OPTIMIZE-HF). Objective: To identify the echocardiographic variables with independent prognostic value and to test their incremental value to a clinical score. Methods: Prospective cohort of patients consecutively admitted between January 2013 and January 2015, with diagnosis of acutely decompensated heart failure, followed up to 60 days after discharge. Inclusion criteria were raised plasma level of NT-proBNP (> 450 pg/ml for patients under 50 years of age or NT-proBNP > 900 pg/ml for patients over 50 years of age) and at least one of the signs and symptoms: dyspnea at rest, low cardiac output or signs of right-sided HF. The primary outcome was the composite of death and readmission for decompensated heart failure within 60 days. Results: Study participants included 110 individuals with average age of 68 ± 16 years, 55% male. The most frequent causes of decompensation (51%) were transgression of the diet and irregular use of medication. Reduced ejection fraction (<40%) was present in 47% of cases, and the NT-proBNP median was 3947 (IIQ = 2370 to 7000). In multivariate analysis, out of the 16 echocardiographic variables studied, only pulmonary artery systolic pressure remained as an independent predictor, but it did not significantly increment the C-statistic of the OPTMIZE-HF score. Conclusion: The addition of echocardiographic variables to the OPTIMIZE-HF score, with the exception of left ventricular ejection fraction, did not improve its prognostic accuracy concerning cardiovascular events (death or readmission) within 60 days

Value (mathematics)

10.6084/m9.figshare.5634622

Cite

Citations (0)

I Diretriz de Ressonância e Tomografia Cardiovascular da Sociedade Brasileira de Cardiologia Sumário Executivo

Arquivos Brasileiros de Cardiologia (2006)

C Cattani Dany Jasinowodolinsk Fabiano Lucchesi Fábio Berezowsky Rocha Fátima Cristina Pedroti

Cesar Augusto Mastrofrancisco Cattani, Dany Jasinowodolinsk, Fabiano Lucchesi, Fabio Berezowsky Rocha, Fatima Cristina Pedroti, Gilberto Szarf, Guilherme Urpia Monte, Iugiro Roberto Kuroki , Joalbo Andrade, Jose Rodrigues Parga Filho, Luis Claudio Correia, Luiz Francisco Avila, Marcelo Hadlich, Marcelo Zapparoli, Marcia Barbosa, Marcia Lima Mugnaini, Maria Helena Albernaz Siqueira, Marly Maria Uellendhal, Miguel Abraao Rosario Neto, Paulo R. Schwarzman, Raul Dias dos Santos Filho, Ricardo Loureiro, Roberto Kalil Filho, Robson de Macedo Vieira

10.1590/s0066-782x2006002200001

Cite

Citations (9)

Maior letalidade e morbidade por infarto agudo do miocárdio em hospital público, em Feira de Santana - Bahia

Arquivos Brasileiros de Cardiologia (2009)

Graça Maria Tavares de Melo Ferreira Luís Cláudio Lemos Correia Helena Reis Carlos Brandão Ferreira Filho Francisco Freitas

Factors related to socioeconomic status and health care quality and management may influence mortality and morbidity rates due to acute myocardial infarction (AMI).To compare mortality and morbidity in patients with AMI hospitalized in public and private hospitals.An observational study, with comparison groups. Clinical evaluation on admission, and recording of diagnostic, therapeutic and evolution data until discharge or death. Comparison of clinical characteristics by univariate analysis followed by bivariate analysis, evaluating the combination of predictors with death and morbidity (Killip> I), SPSS, version 13.0.150 patients were evaluated, 63 (42.0%) of private hospitals and 87 (58.0%) of public hospitals, with 63.1% and 62.1% of males, aged 61.1 +/- 13.8 and 60.0 +/- 11.6 years, respectively. The mortality from AMI was 19.5% in public hospitals vs 4.8% in private hospitals (p = 0.001), and morbidity (Killip class> I) was 34.3% in public hospitals vs 15.0% in private hospitals (p = 0.012). There was a significant difference between public and private patients, due to lower family income and education (70.1% with one to two salaries vs 19.0%, p <0.001, and 49.4% of illiterates vs 6.3%, p <0.001, respectively ); late arrival at the hospital (HAT> 1 hour: 76.9% vs 48.6%, p = 0.003); and a longer period of time before being medicated (AMT > 15 minutes: 47.1% vs 8.0%; p <0.001); ICU for 8% of the patients in public hospitals vs 94% in private hospitals; and thrombolysis for 20.6% vs 54.0%, respectively (p <0.001).Mortality and morbidity were greater among public patients, which presented more serious conditions, arrived later at the hospital and received lower quality treatment.

Killip class

Univariate analysis

Private practice

10.1590/s0066-782x2009000800006

Cite

Citations (23)

Proceedings of the 3rd RILEM Spring Convention and Conference (RSCC 2020)

Rilem bookseries (2022)

José Sena-Cruz Luís Cláudio Lemos Correia Miguel Azenha

10.1007/978-3-030-76465-4

Cite

Citations (3)

Effect of atorvastatin (80 mg) on recurrent ischemia in unstable angina pectoris or Non–ST-Elevation acute myocardial infarction

The American Journal of Cardiology (2003)

Luís Cláudio Lemos Correia Luiz Pereira de Magalhães Oto Santana Mário de Seixas Rocha Luíz Carlos Santana Passos

Cerivastatin

Unstable angina

Endothelial Dysfunction

10.1016/s0002-9149(03)00330-8

Cite

Citations (6)

Endothelial Effect of Statin Therapy at a High Dose Versus Low Dose Associated with Ezetimibe

Arquivos Brasileiros de Cardiologia (2016)

Maristela Magnavita Oliveira Garcia Carolina Garcez Varela Patricia Fontes Silva Paulo Roberto Passos Lima Paulo Meira Góes

Background: The effect of statins on the endothelial function in humans remains under discussion.Particularly, it is still unclear if the improvement in endothelial function is due to a reduction in LDL-cholesterol or to an arterial pleiotropic effect.Objective: To test the hypothesis that modulation of the endothelial function promoted by statins is primarily mediated by the degree of reduction in LDL-cholesterol, independent of the dose of statin administered.Methods: Randomized clinical trial with two groups of lipid-lowering treatment (16 patients/each) and one placebo group (14 patients).The two active groups were designed to promote a similar degree of reduction in LDL-cholesterol: the first used statin at a high dose (80 mg, simvastatin 80 group) and the second used statin at a low dose (10 mg) associated with ezetimibe (10 mg, simvastatin 10/ezetimibe group) to optimize the hypolipidemic effect.The endothelial function was assessed by flow-mediated vasodilation (FMV) before and 8 weeks after treatment.Results: The decrease in LDL-cholesterol was similar between the groups simvastatin 80 and simvastatin 10/ezetimibe (27% ± 31% and 30% ± 29%, respectively, p = 0.75).The simvastatin 80 group presented an increase in FMV from 8.4% ± 4.3% at baseline to 11% ± 4.2% after 8 weeks (p = 0.02).Similarly, the group simvastatin 10/ezetimibe showed improvement in FMV from 7.3% ± 3.9% to 12% ± 4.4% (p = 0.001).The placebo group showed no variation in LDL-cholesterol level or endothelial function. Conclusion:The improvement in endothelial function with statin seems to depend more on a reduction in LDL-cholesterol levels, independent of the dose of statin administered, than on pleiotropic mechanisms.(

Ezetimibe

10.5935/abc.20160048

Cite

Citations (9)

Is Reclassification of Intermediate-Risk Subjects by Coronary Artery Calcium Scoring Clinically Useful?

Journal of the American College of Cardiology (2011)

Luís Cláudio Lemos Correia Anis Rassi

10.1016/j.jacc.2010.11.085

Cite

Citations (1)